Roman PADUCH, Anna WOZNİAK, Piotr NİEDZİELA, Robert REJDAK

Assessment of Eyebright (Euphrasia Officinalis L.) Extract Activity in Relation to Human Corneal Cells Using In Vitro Tests

Background:Euphrasia officinalisL. is anherbtraditionally usedin folk medicine, mainly in the treatment of eye disorders. Aims:Thepresent study analyzed theactivity of three extracts of E. officinalis L.(ethanol, ethyl acetate andheptane) oncultured human corneal epithelial cells (10.014 pRSV-T). Study Design:In vitro study.Methods:Toxicity, freeradical scavenging activity andtheimmu-nomodulatory effects oftheextracts were tested using thethiazo-lylbluetetrazolium bromide (MTT) orNeutral Red,2,2-Diphenyl-1-picrylhydrazyl (DPPH) andELISA tests, respectively. Moreover, nitric oxide levels andcytoskeleton architecture wereanalyzed after corneal cell incubation with the plant extracts.Results:Weshow thatthebiological effect depended onboththe concentration andtheextraction solvent used. Heptane extracts,distinct from those inethanol andethyl acetate, were toxic to 10.014 pRSV-T cells atlowconcentrations (25?g/mL) anddid notdemonstrate freeradical scavenging effects. Alltested extractsdecreased pro-inflammatory cytokine expression (IL-1?, IL-6and TNF-?) andalsoanti-inflammatory IL-10 expression byhumancorneal cellswhen theextracts were added to thecellculture me-dium for 24 h.Conclusion:In conclusion, weshow thatthepromising effects of the application of E. officinalis L. preparations as a supplementary thera-pyforeyedisorders areassociated withtheethanol andethyl acetate extracts, not the heptane extract.

PDF

___

Petrichenko VM, Sukhinina TV, Babiyan LK, Shramm NI. Chemical com- position and antioxidant properties of biologically active compounds from Euphrasia brevipila. Pharm Chem J 2006;40:312-6. [CrossRef]
Stoss M, Michels C, Peter E, Beutke R, Gorter RW. Prospective co- hort trial of Euphrasia single-dose eye drops in conjunctivitis. J Altern Complement Med 2000;6:499-508. [CrossRef]
Blazics B, Alberti A, Kéry A. Antioxidant activity of different pheno- lic fractions separated from Euphrasia rostkoviana Hayne. Acta Pharm Hung 2009;79:11-6.
Citarasu T. Herbal biomedicines: a new opportunity for aquaculture in- dustry. Aquacult Int 2010;18:403-14. [CrossRef]
Kozlowski J, Krajewska A. Ziele swietlika jako leczniczy surowiec roslinny. Farm Pol 1982;38:471-4 (in polish).
Porchezhian E, Ansari SH, Shreedharan NKK. Antihyperglycemic activity of Euphrasia officinale leaves. Fitoterapia 2000;71:522-6. [CrossRef]
Ríos JL, Recio MC. Medicinal plants and antimicrobial activity. J Eth- nopharmacol 2005;100:80-4. [CrossRef]
Trovato A, Monforte MT, Forestieri AM, Pizzimenti F. In vitro anti- mycotic activity of some medicinal plants containing flavonoids. Boll Chim Farm 2000;139:225-7.
Dharma P, Singh G. A Review of Plant Species Used to Treat Conjunc- tivitis. Review article. Phytother Res 2002;16:1-22. [CrossRef]
Bielory L, Heimall J. Review of complementary and alternative medi- cine in treatment of ocular allergies. Curr Opin Allergy Clin Immunol 2003;5:395-9. [CrossRef]
Aburjai T, Natsheh FM. Plants used in cosmetics. Phytother Res 2003;17:987-1000. [CrossRef]
Ganbold M, Barker J, Ma R, Jones L, Carew M. Cytotoxicity and bioa- vailability studies on a decoction of Oldenlandia diffusa and its fractions separated by HPLC. J Ethnopharmacol 2010;131:396-403. [CrossRef]
Paduch R, Matysik G, Wójciak-Kosior M, Kandefer-Szerszen M, Skalska-Kaminska A, Nowak-Kryska M, et al. Lamium album extracts express free radical scavenging and cytotoxic activities. Polish J Envi- ron Stud 2008;17:569-80.
Revoltella RP, Papini S, Rosellini A, Michelini M. Epithelial stem cells of the eye surface. Cell Prolif 2007;40:445-61. [CrossRef]
Wylegala E, Dobrowolski D, Nowinska A, Tarnawska D. Anterior seg- ment optical coherence tomography in eye injuries. Graefes Arch Clin Exp Ophthalmol 2009;247:451-5. [CrossRef]
Chana HS, Schwab L, Foster A. With an eye to good practice. Traditio- nal healers in rural communities. World Health Forum 1994;15:144-6.
West AL, Fetters MD, Hemmila MR, Gorenflo DW, Kiyota A, Moroi-Fet- ters S. Herb and vitamin supplementation use among a general ophthalmo- logy practice population. Am J Ophthalmol 2005;139:522-9. [CrossRef]
Calixto JB, Campos MM, Otuki MF, Santos ARS. Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Med 2004;70: 93-103. [CrossRef]
Shestakova TS, Petrichenko VM, Sukhinina TV. Elemental compositi- on of Euphrasia brevipila herbs and extracts. Pharm Chem J 2008;42: 460-2. [CrossRef]
Baudouin C. The pathology of dry eye. Surv Ophthalmol 2001;45 (Suppl. 2):S211-20. [CrossRef]
Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Expe- rimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 2004;45:4293-301. [CrossRef]
Yeh S, Song XJ, Farley W, Li DQ, Stern ME, Pflugfelder SC. Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Oph- thalmol Vis Sci 2003;44:124-9. [CrossRef]
Achike FI, Kwan Ch-Y. Nitric oxide, human diseases and the herbal pro- ducts that affect the nitric oxide signalling pathway. Clin Exp Pharmacol Physiol 2003;30:605-5. [CrossRef]
Kim PKM, Zamora R, Petrosko P, Billiar TR. The regulatory role of nitric oxide in apoptosis. Int Immunopharmacol 2001;1:1421-41. [CrossRef]
Schmitt ChA, Dirsch VM. Modulation of endothelial nitric oxide by plant-derived products. Nitric Oxide 2009;21:77-91. [CrossRef]